Safety and tolerability of azithromycin in pediatric infectious diseases: 2003 update

Area of Science:

• Pediatric Pharmacology
• Infectious Disease Therapeutics

Background:

• Oral azithromycin suspension is widely prescribed, with over 80 million patients receiving it.
• Pediatric formulations are designed for palatability and good tolerability in children.

Purpose of the Study:

• To evaluate the tolerability and adverse event profile of oral azithromycin suspension in pediatric patients.
• To compare the safety of conventional and alternative dosing regimens.

Main Methods:

• Review of patient data for oral azithromycin suspension use.
• Analysis of treatment-related adverse events and their severity.
• Comparison of adverse event rates across different dosing regimens.

Main Results:

• Azithromycin suspension is generally well-tolerated, with a favorable taste and color for children.
• Approximately 9% of patients experience treatment-related adverse events, primarily mild to moderate gastrointestinal complaints.
• Newer regimens (single 30 mg/kg dose, 3-day 20 mg/kg/day) are well-tolerated but show a trend toward increased adverse effects.

Conclusions:

• Oral azithromycin suspension is a safe and effective antibiotic option for children.
• Most adverse events are mild and rarely require treatment discontinuation.
• While alternative dosing regimens are viable, careful consideration of potential increased side effects is warranted.